European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1293-1298, December 2008

Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised

Bedfordshire and Hertfordshire Breast Screening Unit and Luton & Dunstable Breast Unit, Luton & Dunstable Hospital, Luton, Bedfordshire LU4 0DZ, United Kingdom

Accepted 11 November 2007.

Abstract 

Background

Screen-detected breast lesions in the National Health Service Breast Screening Programme (NHSBSP) are assessed by core needle biopsy (CB) or fine needle aspiration cytology (FNAC). Most core biopsies are diagnostic and representative, but a small proportion is indeterminate (coded “B3” in the NHSBSP). We studied the surgical outcome of screen-detected breast lesions with indeterminate (B3) CB.

Methods

We retrieved and analysed the data on women who were recalled for assessment of a screen-detected abnormality in whom the initial CB was reported as B3 over a six-year period from a prospectively collected database in one breast screening centre. The main outcome measure was final histology following surgical excision.

Results

Among 4080 CB performed, 220 (5.4%) were B3. Mammographically 127 lesions were microcalcifications and 88 were soft tissue lesions. On surgical excision (n=199, 90%), 67 (34%) were malignant. In patients with malignancy, clinical examination, US and concurrent FNAC were either suspicious or definitive of malignancy only in 2%, 4% and 7%, respectively.

Conclusion

A third of screen-detected breast lesions with indeterminate CB are malignant on excision. Clinical examination, US, and FNAC may identify some of these carcinomas pre-operatively but most malignancies would not be picked up. Thus, these lesions should undergo surgical excision.

Keywords: Breast carcinoma, Breast screening, Core needle biopsy, Indeterminate histology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(07)00610-5

doi:10.1016/j.ejso.2007.11.005

European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1293-1298, December 2008